Danijal Topcic

Danijal Topcic is a seasoned professional in the field of biotechnology with extensive experience in stem cell research and process development. Currently serving as the MSAT/Process Development Manager at Procella Therapeutics AB since February 2019, Danijal oversees the transition of scientific knowledge from development to GMP-compliant manufacturing for regenerative therapies. Previously, Danijal held roles such as Senior Scientist and Scientist at Procella Therapeutics, contributing to the creation of process platforms for innovative stem cell therapies and collaborating with AstraZeneca on treatments for heart failure. Prior experience includes a Senior Researcher/Manager role at Karolinska Institutet, a Postdoctoral Research Fellow position at Ludwig Cancer Research, and research work at Baker Heart and Diabetes Institute and the University of Sydney. Danijal holds a PhD in Molecular Cell Biology from the University of Melbourne and a Bachelor of Science (Honours) in Molecular Biology/Biotechnology from Victoria University.